Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Infant Study of Inhaled Saline in Cystic Fibrosis (ISIS)

This study has been completed.
Cystic Fibrosis Foundation Therapeutics
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
CF Therapeutics Development Network Coordinating Center Identifier:
First received: July 1, 2008
Last updated: February 11, 2013
Last verified: February 2013